|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300069092 |
|
最近更新日期: Date of Last Refreshed on: |
2023-05-21 21:54:45 |
|
注册时间: Date of Registration: |
2023-03-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于椅旁数字化技术的医护技一体化临床诊疗标准流程的研究 |
|
Public title: |
Research on clinical diagnosis and treatment standard chair-side process of medical and nursing technology integration based on digital technology |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于椅旁数字化技术的医护技一体化临床诊疗标准流程的研究 |
|
Scientific title: |
Research on clinical diagnosis and treatment standard chair-side process of medical and nursing technology integration based on digital technology |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
蓝冬萍 |
研究负责人: |
满毅 |
|
Applicant: |
Lan Dongping |
Study leader: |
Man Yi |
|
申请注册联系人电话: Applicant telephone: |
18408206787 |
研究负责人电话: Study leader's telephone: |
13308083783 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
landongping20@163.com |
研究负责人电子邮件: Study leader's E-mail: |
manyi780203@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
https://www.hxkq.org/ |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
四川省成都市人民南路三段14号 |
研究负责人通讯地址: |
四川省成都市人民南路三段14号 |
|
Applicant address: |
14Third Section, Renmin Road South, Chengdu, Sichuan, China |
Study leader's address: |
14Third Section, Renmin Road South,Chengdu, Sichuan, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
四川大学华西口腔医院 |
||
|
Applicant's institution: |
West China Hospital of Stomatology, Sichuan University |
||
|
研究负责人所在单位: |
四川大学华西口腔医院 |
||
|
Affiliation of the Leader: |
West China Hospital of Stomatology, Sichuan University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
WCHSIRB-CT-2022-405 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川大学华西口腔医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the West China Hospital of Stomatology |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-12-08 00:00:00 |
||
|
伦理委员会联系人: |
李伟 |
||
|
Contact Name of the ethic committee: |
Li Wei |
||
|
伦理委员会联系地址: |
四川省成都市人民南路三段14号 |
||
|
Contact Address of the ethic committee: |
14Third Section, Renmin Road South, Chengdu, Sichuan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
四川大学华西口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
West China Hospital of Stomatology, Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
四川省成都市人民南路三段14号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
14Third Section, Renmin Road South, Chengdu, Sichuan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
横向课题经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
latitudinal projects funding |
||||||||||||||||||||||
|
Target disease: |
Dentition Defect |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
基于椅旁系统设备,建立一个标准化、高效化的医护技一体的椅旁诊疗流程 |
||||||||||||||||||||||
|
Objectives of Study: |
Establish a standardized and efficient chair-side diagnosis and treatment process integrating medical care and technology based on chair-side system equipment |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. 患者自愿参加临床试验并签署知情同意书; 2. 18—70岁(含18岁和70岁)的患者,性别不限; 3. 患有牙列缺损或缺失需进行种植修复,符合牙种植体修复术指征的患者; 4. 依从性良好,愿意并且能够按要求进行随访观察; 5. 剩余牙列情况、缺牙间隙、咬合关系、颌骨形态、张口度等均满足修复要求。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients voluntarily participate in clinical trials and signed informed consent; 2. Patients aged 18-70 (including 18 and 70), the gender is not limited; 3. Patients with dental dental defects or lack of planting, patients who meet the indications of dental implant repair; 4. Good compliance, willingness and being able to follow up as required; 5. The remaining dental rosses, lack of gaps, occlusion relationships, jaw shapes, and tensor, etc. meet the repair requirements. |
||||||||||||||||||||||
|
排除标准: |
1. 3个月内参加过其它医疗器械试验者; 2. 对产品所用材料过敏; 3. 患者内分泌代谢性疾病、血液系统疾病及心血管疾病等未控制者; 4. 系统或局部的骨性疾病,如骨结核、骨炎、骨肿瘤等; 5. 患有系统性免疫性疾病者; 6. 神经系统疾病,如癫痫患者; 7. 精神病患者或有心理障碍者; 8. 病理性粘膜病变; 9. 头颈部放疗后; 10. 尚未控制的牙周病或口腔卫生极差者; 11. 不良咬合习惯者,夜磨牙等; 12. 骨量不足和/或骨质欠佳; 13. 颌骨发育不全或病理性改变; 14. 口腔干燥综合征; 15. 哺乳期、妊娠期妇女; 16. 长期服用特殊药物者如激素、抗凝药等; 17. 酒精或药物成瘾性患者; 18. 研究者认为其他不适合试验的情况。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Participants who have participated in other medical device tests within 3 months; 2. Allergies to the materials used in the product; 3. Patients with endocrine metabolic diseases, blood system diseases and cardiovascular diseases; 4. Systems or local osteadic diseases, such as bone tuberculosis, osteitis, osteooma, etc.; 5. Those who have systemic immune diseases; 6. Neurological diseases, such as patients with epilepsy; 7. Patients with mental illness or those with psychological disorders; 8. Pathological mucosal lesions; 9. After the head and neck radiotherapy; 10. Those who have not controlled periodontal disease or oral hygiene are extremely poor; 11. If the habit of bite the habit, night grind teeth, etc.; 12. Insufficient bone mass and/or bone quality; 13. Jaw bone development or pathological changes; 14. Oral drying syndrome; 15. Women during lactation and pregnancy; 16. Those who take special drugs for a long time, such as hormones, anticoagulant drugs, etc.; 17. Alcohol or drug addiction patients; 18. Researchers believe that other is not suitable for testing. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-03-15 00:00:00至 To 2025-03-15 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-03-15 00:00:00 至 To 2025-03-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
队列研究,无法随机 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Queen research, cannot be random |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
ResMan 临床试验公共管理平台, http://www.medresman.org.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
ResMan, http://www.medresman.org.cn. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
ResMan |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
ResMan |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |